In Vietnam, STADA Pymepharco proudly owns one of the largest pharmaceutical portfolios among both international and local companies – with nearly 400 products, including around 250 Generic (Rx) medicines and close to 150 Consumer Healthcare (CHC) products.
By combining the global expertise of STADA Group with deep market insights and a strong local legacy, STADA Pymepharco continuously expands its portfolio to deliver German-standard healthcare solutions – meeting the growing and diverse needs of domestic consumers while supporting a long-term strategy for sustainable export growth.